Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics achieved a significant finding in ...

Columbia Engineering and Irving Institute researchers unveil a significant finding in cancer immunotherapy, uncovering unique ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

has now shown that TP53-mutant AML cells are also significantly more resistant to a new type of immunotherapy—CAR T-cell therapy—than AML cells without the mutated gene. The paper is published ...

In this regard, natural killer (NK) cell-based immunotherapy has attracted clinical interest due to its critical role in immunosurveillance and their capabilities to target AML blasts. NK cells ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics achieved a significant finding in cancer immunotherapy. The Tribune, now published from Chandigarh ...

In cancer immunotherapy, T cells are often the stars of the show ... cells when he realized that they offered a unique opportunity to treat blood cancers like acute myeloid leukemia (AML). Previous ...

Avalon’s lead CAR γδ T cell therapeutic candidates targeting relapsed and refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), as well as multiple solid tumors ...